Remdesivir (new drug approved for Covid):
"What are the important possible side effects of Veklury (remdesivir)?
Possible side effects of Veklury are:
• Allergic reactions. Veklury can cause allergic reactions, including serious reactions, during and after infusion.
Tell your healthcare provider or nurse, or get medical help right away if you get any of the following signs and
symptoms of allergic reactions: low blood pressure, changes in your heartbeat, shortness of breath, wheezing,
swelling of your lips, face, or throat, rash, nausea, vomiting, sweating, or shivering.
• Increases in levels of liver enzymes. Increases in levels of liver enzymes have been seen in people who have
received Veklury, which may be a sign of inflammation or damage to cells in the liver. Your healthcare
provider will do blood tests to check your liver before you receive Veklury and daily while receiving Veklury.
These are not all the possible side effects of Veklury. Veklury is still being studied so it is possible that all of the
risks are not known at this time.
Not a lot of people have taken Veklury. Serious and unexpected side effects may happen. The side effects of
getting any medicine by vein may include brief pain, bleeding, bruising of the skin, soreness, swelling, and
possible infection at the injection site."
....
"What is Veklury (remdesivir)?
Veklury is an investigational antiviral medicine used for the treatment of certain people in the hospital with COVID19. Veklury is investigational because it is still being studied. There is limited information known about
the safety
and effectiveness of using Veklury to treat people in the hospital with COVID-19. Veklury was shown in a clinical
trial to shorten the time to recovery in some people. There are no medicines approved by the FDA as safe and
effective to treat people in the hospital who have COVID-19. Therefore, the FDA has authorized the emergency
use of Veklury for the treatment of COVID-19 under an Emergency Use Authorization (EUA). For more information
on EUA, see the “What is an Emergency Use Authorization (EUA)?” section at the end of this Fact Sheet."
https://www.fda.gov/media/137565/download#:~:text=not%20a%20lot%20of%20people,infection%20at%20the%20injection%20site.